Traynor Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25M Sell
62,985
-3,545
-5% -$1.55M 1.15% 17
2026
Q1
$30.1M Buy
66,530
+742
+1% +$375K 1.77% 10
2025
Q4
$37.3M Buy
65,788
+1,908
+3% +$1.02M 1.99% 9
2025
Q3
$28.6M Buy
63,880
+8,730
+16% +$4.19M 1.63% 11
2025
Q2
$29.7M Buy
55,150
+7,077
+15% +$3.7M 2.1% 9
2025
Q1
$23.8M Buy
48,073
+6,939
+17% +$3.84M 2.01% 9
2024
Q4
$21.5M Buy
41,134
+4,771
+13% +$2.48M 1.43% 12
2024
Q3
$17.9M Buy
36,363
+16,161
+80% +$7.52M 1.07% 18
2024
Q2
$8.99M Buy
20,202
+11,077
+121% +$4.41M 0.67% 28
2024
Q1
$3.64M Buy
9,125
+4,207
+86% +$1.59M 0.32% 50
2023
Q4
$1.66M Buy
4,918
+961
+24% +$286K 0.17% 73
2023
Q3
$1.16M Buy
3,957
+912
+30% +$285K 0.14% 75
2023
Q2
$1.04M Buy
3,045
+405
+15% +$123K 0.13% 84
2023
Q1
$674K Buy
2,640
+140
+6% +$34.5K 0.1% 105
2022
Q4
$663K Buy
2,500
+1,010
+68% +$246K 0.09% 109
2022
Q3
$279K Sell
1,490
-4
-0.3% -$859 0.05% 135
2022
Q2
$299K Sell
1,494
-100
-6% -$23.5K 0.05% 121
2022
Q1
$480K Sell
1,594
-10,662
-87% -$3.11M 0.06% 115
2021
Q4
$4.4M Buy
12,256
+7,717
+170% +$2.66M 0.52% 43
2021
Q3
$1.5M Buy
4,539
+3,432
+310% +$1.15M 0.21% 72
2021
Q2
$346K Buy
+1,107
New +$311K 0.05% 130
2020
Q1
Sell
-31,524
Closed -$6.21M 168
2019
Q4
$6.21M Buy
31,524
+516
+2% +$96.6K 1.66% 12
2019
Q3
$5.58M Buy
31,008
+819
+3% +$142K 1.75% 12
2019
Q2
$5.33M Sell
30,189
-1,413
-4% -$242K 1.73% 11
2019
Q1
$6.01M Buy
31,602
+2,112
+7% +$375K 2.01% 11
2018
Q4
$4.71M Buy
29,490
+174
+0.6% +$29.5K 1.96% 10
2018
Q3
$5.61M Buy
29,316
+1,293
+5% +$230K 1.82% 12
2018
Q2
$4.55M Buy
28,023
+879
+3% +$134K 1.66% 11
2018
Q1
$3.73M Buy
27,144
+2,163
+9% +$302K 1.52% 13
2017
Q4
$3.04M Buy
24,981
+2,139
+9% +$268K 1.3% 16
2017
Q3
$2.61M Buy
22,842
+7,713
+51% +$840K 1.24% 17
2017
Q2
$1.57M Buy
15,129
+3,438
+29% +$330K 0.77% 27
2017
Q1
$1.16M Buy
+11,691
New +$924K 0.65% 31

Other funds holding ISRG

Traynor Capital Management's ISRG Position: Q2 2026 in Review

Traynor Capital Management reduced its Intuitive Surgical (ISRG) stake by 5.3% in Q2 2026, selling an estimated $1.55M and leaving 62,985 shares worth $25M. The position accounts for 1.15% of the portfolio, ranked #17.

Traynor Capital Management first reported a position in ISRG in Q1 2017 and has held it in 33 quarters since. The position peaked at $37.3M in Q4 2025. 636 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Traynor Capital Management held 62,985 shares of Intuitive Surgical worth $25M as of Q2 2026.
  • Traynor Capital Management sold 3,545 Intuitive Surgical shares in Q2 2026, an estimated $1.55M.
  • Intuitive Surgical made up 1.15% of Traynor Capital Management's portfolio in Q2 2026, its #17 holding.
  • Traynor Capital Management first reported a position in Intuitive Surgical in Q1 2017 and has held it in 33 quarters since.
  • Traynor Capital Management's Intuitive Surgical position peaked at $37.3M in Q4 2025.
  • 636 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.